NCN. R. B. Chaves

N. R. B. Chaves

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

N. R. B. Chaves has a total of 4 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Eugenol and cinnamaldehyde in the prevention of cariogenic biofilm formation: a narrative review

    by N. R. B. Chaves, J. S. S. A. Carneiro, F. L. F. David, J. M. M. Araújo, A. S. Monteiro

    Dental caries is a multifactorial disease with high global prevalence, associated with biofilm formation by microorganisms such as Streptococcus mutans and species of the Lactobacillus genus. Natural compounds, such as eugenol from clove and trans-cinnamaldehyde from cinnamon, have demonstrated antimicrobial and antibiofilm potential, offering promising alternatives for caries management. This narrative review synthesized studies published between 2015 and 2025, retrieved from PubMed, SciELO, and BVS/LILACS, addressing the efficacy of these compounds in in vitro and in vivo models. Findings indicate that eugenol and trans-cinnamaldehyde reduce biofilm biomass and viability, interfere with acidogenesis, and modulate bacterial virulence genes. Additionally, controlled-release systems and formulations combined with conventional agents, such as chlorhexidine and fluoride, enhance their activity, reducing therapeutic doses and adverse effects. Despite their effectiveness in laboratory assays, controlled clinical studies are still necessary to consolidate their use in dental practice. Overall, eugenol and trans-cinnamaldehyde demonstrate promising antibiofilm and antimicrobial properties in experimental studies and may represent potential candidates for future preventive